Getz Pharma Company Profile

Background

Overview

Established in 1995, Getz Pharma is an international, research-driven, branded generic pharmaceutical company headquartered in Karachi, Pakistan. The company is dedicated to developing, producing, and marketing safe, effective, and high-quality medicines and healthcare products aimed at improving the health and quality of life for individuals globally.

Mission and Vision

Getz Pharma's mission is to enhance global health by delivering quality medicines to patients worldwide with integrity. The company envisions becoming a global leader in the pharmaceutical industry, recognized for its contributions to global health and well-being.

Primary Area of Focus

The company specializes in the formulation development, manufacturing, testing, and marketing of a wide range of quality, affordable medicines across various therapeutic segments, including cardiometabolic, gastroenterology, hepatology, pulmonology, urology, gynecology, oncology, pediatrics, orthopedics & rheumatology, infectious diseases, neuropsychiatry, general medicine, and nephrology.

Industry Significance

Getz Pharma is the largest branded generic pharmaceutical company in Pakistan and has expanded its operations to over 45 countries, employing more than 8,000 individuals worldwide. The company is recognized for its commitment to quality and compliance in the production of finished dosage forms.

Key Strategic Focus

Core Objectives

Develop and market high-quality, affordable medicines globally.

Expand international market presence.

Invest in research and development to drive innovation.

Specific Areas of Specialization

Branded generic pharmaceuticals.

Comprehensive therapeutic portfolio.

Key Technologies Utilized

State-of-the-art manufacturing facilities.

Advanced quality control laboratories.

Integrated management and business systems with complete automation.

Primary Markets Targeted

South Asia.

Central Asia.

Southeast Asia.

Middle East.

Africa.

Financials and Funding

Funding History

As a privately held company, Getz Pharma has not publicly disclosed detailed funding histories or specific funding rounds. The company has achieved significant growth through reinvestment of profits and strategic partnerships.

Total Funds Raised

Specific figures regarding total funds raised are not publicly available.

Notable Investors

As a privately held entity, Getz Pharma's investor information is not publicly disclosed.

Intended Utilization of Capital

Capital is primarily utilized for:

Expansion of manufacturing facilities.

Research and development initiatives.

Market expansion efforts.

Pipeline Development

Key Pipeline Candidates

Getz Pharma's pipeline includes a diverse range of products across various therapeutic areas, with a focus on:

Cardiometabolic diseases.

Gastroenterology.

Infectious diseases.

Stages of Clinical Trials or Product Development

Specific details regarding the stages of clinical trials or product development are not publicly disclosed.

Target Conditions

Hypertension.

Diabetes.

Gastrointestinal disorders.

Infectious diseases.

Relevant Timelines for Anticipated Milestones

Timelines for anticipated milestones are not publicly available.

Technological Platform and Innovation

Proprietary Technologies

Advanced manufacturing facilities adhering to international standards.

Integrated management and business systems with complete automation.

Significant Scientific Methods

Comprehensive approach to new product development, including literature reviews, pre-formulation studies, analytical method development, formulation optimization, stability studies, and manufacturing process development.

AI-Driven Capabilities

Specific AI-driven capabilities are not publicly disclosed.

Leadership Team

Executive Profiles

Khalid Mahmood: Group CEO of Getz Pharma & Getz Life.

Khurram Hussein: Managing Director of Getz Pharma & Getz Life.

Adnan Siddiqui: Chief Operating Officer, Quality Operations.

Azhar Zuberi: Director, Information Technology.

Hassan Ahmad: Chief Operating Officer, Getz Life.

Juman Khan: Chief Commercial Officer, Pakistan Business.

Mahmood A. Aziz: Executive Vice President, Strategic Sourcing and Special Projects.

Mohammed Hanif Ajari: Senior Vice President, International T&T and Company Secretary.

Sadi Syed: Chief Operating Officer, Plant Engineering and Projects.

Salman Goheer: Chief Supply Chain Officer.

Shahid Memon: Director, Legal Affairs.

Yahya Zakaria: Chief Financial Officer.

Zeeshan Ahmed: Chief Operating Officer, Innovation and Business Development.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical industry in Pakistan is characterized by a large number of companies, with Getz Pharma being the sixth largest in terms of annual sales among approximately 500 pharmaceutical companies operating in the country.

Competitor Analysis

Key competitors in the Pakistani pharmaceutical market include:

Dvago: An online pharmacy offering a wide range of pharmaceutical and wellness products.

PharmEvo: A pharmaceutical company providing a variety of health products.

Medpk: An online platform for medical information and services.

DrugInfosys: Provides details of drug molecules, therapeutics, pharmacology, and prescribing information.

Genix Pharma: A pharmaceutical company offering a range of health products.

Strategic Collaborations and Partnerships

Getz Pharma has established partnerships with organizations like Karwan-E-Hayat, Dow University of Health Sciences, and Henlius Biotech Co. Ltd. These collaborations present cross-selling opportunities and potential avenues for joint ventures in healthcare services and research.

Operational Insights

Getz Pharma's manufacturing facility is pre-qualified and approved by the World Health Organization (WHO), and complies with the standards of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and the Eurasian Economic Union (EAEU). Notably, it is the only pharmaceutical manufacturing company in South Asia to achieve the LEED Platinum Certification from the U.S. Green Building Council (USGBC).

Strategic Opportunities and Future Directions

Strategic Roadmap

Getz Pharma aims to:

Expand its global market presence.

Enhance research and development capabilities.

Strengthen strategic partnerships and collaborations.

Future Business Directions

The company is focused on:

Developing new therapeutic products.

Entering new international markets.

Investing in sustainable manufacturing practices.

Opportunities for Expansion

Opportunities include:

Leveraging existing partnerships for market expansion.

Utilizing its LEED Platinum-certified facility to attract environmentally conscious clients.

Positioning for Future Objectives

Getz Pharma's commitment to quality, innovation, and sustainability positions it well to achieve its future objectives in the global pharmaceutical industry.